Barclays Retains an Equal Weight Rating on Ambev S.A. (ABEV)

Ambev S.A. (NYSE:ABEV) is among the 12 Best Alcohol Stocks to Buy Right Now.

On February 17, 2026, Barclays boosted Ambev S.A. (NYSE:ABEV)’s price objective to $3 from $2.50. The analyst retained an Equal Weight rating, noting a focus on profitability-led earnings and cash flow growth in 2026.

On February 12, 2026, Ambev S.A. (NYSE:ABEV) announced fourth-quarter organic net revenue growth of 4.8%, driven by an 8.7% increase in net revenue per hectoliter, while total volume fell 3.6%. Full-year organic net revenue grew by 4.0%, with a 7.5% rise in net revenue per hectoliter, offsetting a 3.3% volume reduction across activities. The company achieved a 5.6% rise in full-year normalized EBITDA, increasing the margin by 50 basis points to 33.4%, completing the third consecutive year of expansion. The firm reported a fourth-quarter normalized profit of R$4.6 billion, down 8.0%, while full-year normalized profit grew 1.6% to R$15.1 billion. Operating cash flow for the year was R$24.5 billion, down 6.3%.

Ambev S.A. (NYSE:ABEV) produces, distributes, and sells beverages. It manufactures beer, carbonated soft drinks, and various non-alcoholic and non-carbonated products. It functions across the following geographic areas: Brazil, Central America and the Caribbean (CAC), and Canada.

While we acknowledge the potential of ABEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Best Electric Utility Stocks to Invest In Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.

Disclosure: None. Follow Insider Monkey on Google News.